LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer

• Published in: Gene Vol. 901; p. 148165
• Main Authors: Wasson, Marie-Claire D., Venkatesh, Jaganathan, Cahill, Hannah F., McLean, Meghan E., Dean, Cheryl A., Marcato, Paola
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 05.04.2024
• Subjects: Apoptosis; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Cell Proliferation - genetics; Female; Gene Expression Regulation, Neoplastic; Humans; RNA, Long Noncoding - metabolism; UMAP; ILC; PR; TANRIC; BH; LncRNAs; GO; QPCR; IDC; scaRNA; ER; snRNA; snoRNA; TCGA; PCA; TIL; HER2; TNBC; ASO
• ISSN: 0378-1119; 1879-0038
• DOI: 10.1016/j.gene.2024.148165

[Display omitted] •LncRNAs display subtype-specific patient survival correlations in breast cancer.•TNBC-specific AL078604.2 and HER2 + -specific LINC01269 are novel therapeutic targets.•LncRNA expression correlates with tumor immune cell infiltration in a subtype-specific manner. Long non-coding RNAs (lncRNAs) play important roles in cancer progression, influencing processes such as invasion, metastasis, and drug resistance. Their reported cell type-dependent expression patterns suggest the potential for specialized functions in specific contexts. In breast cancer, lncRNA expression has been associated with different subtypes, highlighting their relevance in disease heterogeneity. However, our understanding of lncRNA function within breast cancer subtypes remains limited, warranting further investigation. We conducted a comprehensive analysis using the TANRIC dataset derived from the TCGA-BRCA cohort, profiling the expression, patient survival associations and immune cell type correlations of 12,727 lncRNAs across subtypes. Our findings revealed subtype-specific associations of lncRNAs with patient survival, tumor infiltrating lymphocytes and other immune cells. Targeting of lncRNAs exhibiting subtype-specific survival associations and expression in a panel of breast cancer cells demonstrated a selective reduction in cell proliferation within their associated subtype, supporting subtype-specific functions of certain lncRNAs. Characterization of HER2 + -specific lncRNA LINC01269 and TNBC-specific lncRNA AL078604.2 showed nuclear localization and altered expression of hundreds of genes enriched in cancer-promoting processes, including apoptosis, cell proliferation and immune cell regulation. This work emphasizes the importance of considering the heterogeneity of breast cancer subtypes and the need for subtype-specific analyses to fully uncover the relevance and potential impact of lncRNAs. Collectively, these findings demonstrate the contribution of lncRNAs to the distinct molecular, prognostic, and cellular composition of breast cancer subtypes.